Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

23.96
+0.27001.14%
Volume:2.40M
Turnover:56.91M
Market Cap:2.69B
PE:-15.59
High:24.14
Open:23.61
Low:23.39
Close:23.69
52wk High:81.73
52wk Low:18.92
Shares:112.44M
Float Shares:109.98M
Volume Ratio:0.66
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5368
EPS(LYR):-1.0085
ROE:-19.99%
ROA:-14.99%
PB:3.39
PE(LYR):-23.76

Loading ...

Aug 19, 2025

Major Issues Report

Form 8-K - Current report
Jul 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Correspondence

Form CORRESP - Correspondence
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Proposed Sale Of Securities

Form 144 | VIKING THERAPEUTICS, INC. Director Lawson Macartney proposes to sell 2000 shares, with a total value of approximately $137,334.
Nov 04, 2024

Major Issues Report

Form 8-K - Current report